Daratumumab-based Regimen in Treating Clonal Plasma Cell Neoplasms in Solid Organ Transplant Recipients

Documenti analoghi

• Plasma cell neoplasms in U.S. solid organ transplant recipients
  di: Engels, Eric A., et al.
  Pubblicazione: (2013)
• Liver failure due to relapsed myeloma and hepatic iron overload
  di: Chaulagain, Chakra P, et al.
  Pubblicazione: (2020)
• Increased Risk for Lymphoid and Myeloid Neoplasms in Elderly Solid Organ Transplant Recipients
  di: Quinlan, Scott C., et al.
  Pubblicazione: (2010)
• Arterial thromboembolism in multiple myeloma in the context of modern anti-myeloma therapy
  di: Chakraborty, Rajshekhar, et al.
  Pubblicazione: (2021)
• Management of Primary Plasma Cell Leukemia Remains Challenging Even in the Era of Novel Agents
  di: Chaulagain, Chakra P, et al.
  Pubblicazione: (2021)